Abstract
Endoscopic transpapillary gallbladder stenting (ETGS) in patients with symptomatic gallbladder diseases is a safe and feasible bridge therapy for patients at high risk of surgery and complications, or for patients with terminal liver disease awaiting a transplantation. However, there are few reports considering the long-term results in terms of stent patency and natural clinical course.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
